95 SNPs representing common genetic variation in vitamin D pathway genes. LTL was measured by quantitative PCR, and z-scores within each study were calculated. Associations were assessed by linear as well as logistic regression adjusting for age and other potential confounders. Results Age (P-trend < 0.0001), pack-years of smoking (P-trend = 0.04) and body mass index (P-trend = 0.05) were inversely associated with LTL. Neither 25(OH)D nor 1,25(OH) 2 D was associated with LTL (multivariableadjusted P-trend 0.69 and 0.41, respectively, for the linear regression model). One SNP in the retinoid X receptor alpha gene was associated with long LTL (P = 0.0003). 
Introduction
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fish liver oils and is fortified in milk and cereals. Vitamin D and its metabolites are primarily transported by the vitamin D-binding protein in the circulation. Vitamin D becomes biologically active through two hydroxylations: The first occurs in the liver and converts vitamin D to 25-hydroxyvitamin D (25(OH)D), and the second hydroxylation takes place in various organs to form the physiologically active 1,25-dihydroxyvitamin D (1,25(OH) 2 D), which binds to the vitamin D receptor (VDR) in the cell nucleus. Historically, vitamin D was known to play a main role in regulating calcium metabolism, but more recently, it has been shown to be involved in multiple cellular processes, including those that are cancer related, such as protecting cells against DNA damage, inducing cell cycle arrest and, consequently, inhibiting cell proliferation, increasing apoptosis and inducing differentiation [1, 2] . Vitamin D deficiency is associated with increased incidence of cancer, cardiovascular disease and other chronic illnesses, though there is still uncertainty over whether these associations are causal [3] .
Telomeres consist of telomeric proteins and repetitive DNA sequences (TTAGGG) that protect the ends of linear chromosomes from attrition or from fusion with neighboring chromosomes and are thus important for maintaining chromosome stability. Standard DNA polymerase cannot synthesize the terminal 3′ end of template telomeric DNA during cell division, a phenomenon also called the end replication problem, which results in progressive telomere shortening. The enzyme complex telomerase replicates those sequences, keeping telomere length constant after each cellular division. However, since adult somatic cells typically have low or absent telomerase activity telomeres shorten over cell division in these cells. Therefore, telomere length in somatic cells reflects the cells' replicative history and can predict its remaining proliferative potential. Telomere shortening is accelerated by oxidative stress, inflammation and cell proliferation [4] [5] [6] , and shorter leukocyte telomeres have been associated with increased incidence of chronic diseases such as cancer [7] and cardiovascular disease [8] .
Shorter telomere length has been associated with many chronic diseases that vitamin D protects against, and thus, it can be hypothesized that this protection may be mediated in part through the maintenance of telomere integrity. The presence of 1,25(OH) 2 D receptors in leukocytes supports a direct effect of vitamin D on leukocyte telomere length [9] . Two recent studies found that higher plasma 25(OH) D concentration was significantly associated with longer leukocyte telomere length (LTL) in women [10, 11] . To our knowledge, the association between vitamin D and telomere length in men remains unexplored. Since men in general have shorter telomeres than women [12] , sex differences in the association between vitamin D and telomere length may be present.
In this cross-sectional study of a male cohort, the Health Professionals Follow-up Study (HPFS), we investigated concentrations of circulating 25(OH)D and 1,25(OH) 2 D as well as genetic variants of the vitamin D pathway in relation to telomere length in peripheral blood leukocytes. We also examined whether the association between circulating 25(OH)D and 1,25(OH) 2 D and telomere length was modified by total dietary calcium, folate and retinol.
Materials and methods
Study population
The HPFS cohort includes 51,529 US male health professionals who were aged 40-75 years at enrollment in 1986 when they responded to a questionnaire about their medical history and lifestyle. The men were mailed questionnaires to update this information every 2 years. Detailed dietary information was collected every 4 years. The overall follow-up rate was >94 % [13] . Between 1993 and 1995, 18,018 cohort participants provided blood samples.
Details on blood draw procedures, transportation and storage of plasma samples in these cohorts have been described previously [14] .
Multiple nested case-control studies have been conducted within the HPFS subcohort containing pre-diagnostic blood samples to investigate associations of vitamin D with for example prostate, colon and pancreatic cancer. The present analysis includes data on a total of 2483 men from three of these nested case-control studies (n = 225 based on pancreatic cancer, n = 425 based on colon cancer and n = 1833 based on prostate cancer), with previously measured 25(OH)D, LTL and a completed food frequency questionnaire (FFQ) at the time of blood draw. In addition, 1832 participants from the prostate nested case-control set had a measurement of 1,25(OH) 2 D. The majority (95 %) of the HPFS blood cohort is white men of European ancestry; since both vitamin D concentrations and telomere length differ by race, we restricted the analyses to white men. This study was approved by the Human Subjects Committee of the Harvard T. H. Chan School of Public Health (NIH/NCI R01 CA133891), and written informed consent was obtained from all participants.
Measurement of vitamin D
For the prostate and colon case-control sets, plasma 25(OH)D and 1,25(OH) 2 D measurements (prostate set only) were performed at the laboratory of Dr. Bruce W. Hollis at the Medical University of South Carolina using a radioimmunoassay method [15] . For the pancreatic case-control set, plasma concentrations of 25(OH)D were assayed in the laboratory 1 3 of Dr. Nader Rifai (Children's Hospital, Boston, MA), using the 25-Hydroxyvitamin D Enzyme Immunoassay Kit from Immunodiagnostic Systems. The comparability between the two methods was previously assessed in a separate pilot study (not published) where samples were first measured using the radioimmunoassay and then re-measured using the enzyme immunoassay. The values were highly comparable. The prostate cancer case-control samples were assayed for 25 
Covariate assessment
Intakes of vitamin D, calcium, folate and retinol were calculated using the information from the FFQ closest to the time the blood sample was provided (1994 FFQ) or, if not available, from the most recent questionnaire administered before 1994. Similarly, we used information from the 1994 questionnaire or, if not available, the most recent before 1994 to estimate BMI, smoking amount (indicated by pack-years), alcohol consumption and physical activity (indicated by metabolic equivalent per week; MET/week) at the time of blood donation.
Single nucleotide polymorphism (SNP) selection and genotyping
The SNP selection has been described in detailed elsewhere [18] . Briefly, 97 tagging SNPs (R 2 > 0.8) were selected from seven vitamin D-related genes (VDR, CYP27B1, GC, CYP27A1, CYP2R1, CYP24A1 and RXRA). Selection was restricted to those with a minor allele frequency of greater than 5 % in the reference panel. One SNP in VDR and one in CYP24A1 failed genotyping. Blood samples from matched case-control pairs were handled identically and assayed in the same batch in a blinded fashion. Genotyping was performed at the Dana Farber/Harvard Cancer Center High-Throughput Genotyping Core using the TaqMan Open Array (Applied Biosystems, Foster City, CA). Blinded quality control samples were inserted to validate genotyping procedures. All SNPs had greater than 90 % genotype completion, and the concordance was greater than 99 % for blinded quality control samples. Participants with missing values had their genotypes imputed using the HapMap Phase III CEU data and the MACH imputation program [19] .
Telomere length assay
Genomic DNA was extracted from peripheral blood leukocytes using the QIAmp 96-spin blood protocol (Qiagen, Chatsworth, CA, USA). Pico-Green quantification of genomic DNA was performed using a Molecular Devices 96-well spectrophotometer (Sunnyvale, CA, USA). Relative LTL was determined using a modified, high-throughput version of the quantitative PCR (qPCR)-based telomere assay. The qPCR telomere assay was run on Applied Biosystems 7900HT Sequence Detection System (Foster City, CA, USA). Laboratory personnel were blinded to participant characteristics, and all assays were processed in triplicate by the same technician and under identical conditions. The average relative LTL was calculated as the ratio of telomere repeat copy number to a single-gene (36B4) copy number (T/S). Relative LTL is reported as the exponentiated T/S ratio corrected for a reference sample included on every plate. In all three nested case-control studies, the telomere and single-gene assay CVs for triplicates were less than 1.2 %. CVs for the exponential T/S ratio ranged from 11.8 to 16.0 %. Although this assay provides a relative measurement of telomere length, T/S ratios highly correlate with absolute telomere lengths determined by Southern blot (r = 0.82; p < 0.001) [20] .
Telomere length was assayed in study-specific batches. To minimize the impact of a potential batch effect, z-scores of log-transformed LTL were calculated by standardizing the LTL in comparison with the mean within each individual study.
Statistical analyses
We detected and excluded two outliers based on the lognormalized LTL in the pancreas dataset using the generalized extreme studentized deviate (ESD) test [21] ; both 1 3
were on the short side of the distribution. No outliers were detected in the colon and prostate datasets. Linear regression was used when the telomere length z-score outcome was continuous, and unconditional logistic regression (odds ratios and 95 % confidence intervals) was used when the z-score was dichotomized at the median. We adjusted for age (continuous, years), smoking (0, >0-20, >20-40, >40 pack-years), BMI (continuous, kg/m 2 ), physical activity (continuous, MET/week) and alcohol consumption (continuous, g/day) as potential confounders since these factors have previously been associated with vitamin D and/or telomere length. Missing values of smoking (around 2 %) were treated as a separate missing category. Multiplicative interaction terms involving continuous variables were created to test for effect modification using the Wald test.
The additive genetic model was used for the SNP analyses, which assumes that the effect of the heterozygous genotype is intermediate between the two homozygous genotypes. The homozygous genotype of the reference allele was coded as 0. Age-adjusted linear regression of each individual SNP and continuous LTL as well as unconditional logistic regression with low and high LTL (dichotomized at the median) was performed. The 95 SNPs corresponded to 89 independent tests; consequently, a P value significance threshold of 0.0006 controls the experiment-wide type I error rate at the 0.05 level. In addition, we assessed global associations for SNP sets defined by all seven genes as well as each gene individually using a logistic kernel machine model, described in detail in Shui et al. [18] . All P values were two-sided, and analyses were performed using SAS version 9.2 software (SAS Institute, Cary, NC) or R (http://www.r-project.org/).
Results
Main age-standardized characteristics of the study population by quartiles of telomere length are presented in Table 1 . As expected, there was an inverse correlation between age at blood draw and telomere length: Younger men had longer telomeres (P-trend < 0.0001). Moreover, men with longer telomeres smoked slightly less (P-trend = 0.04) and had lower BMI (P-trend = 0.05) than men with shorter telomeres.
In Table 2 , associations between key variables and plasma 25(OH)D are reported. Men with higher plasma 25(OH)D concentrations had lower BMI (P-trend < 0.0001) and smoked less (P-trend 0.01) than men with lower concentrations, whereas physical activity (P-trend < 0.0001), alcohol consumption (P-trend < 0.0001), calcium, folate, retinol and total dietary vitamin D intake as well as plasma 1,25(OH) 2 D all showed a positive association with plasma 25(OH)D (P-trend = 0.0002 or lower for all).
As depicted in Table 3 , we did not observe an association between plasma vitamin D biomarkers and LTL z-scores, in neither age-adjusted (P-trend = 0.97 for 25(OH)D and 0.34 for 1,25(OH) 2 D) nor multivariable-adjusted models (P-trend = 0.69 for 25(OH)D and 0.41 for 1,25(OH) 2 D). We also performed sensitivity analyses, excluding individuals who later developed cancer. Results did not differ in those analyses restricted to controls; multivariable-adjusted P-trend = 0.72 for 25(OH)D (n = 1356 of whom n = 162 were from the pancreatic cancer set, n = 279 were from the colon cancer set and n = 915 were from the prostate cancer set) and 0.75 for 1,25(OH) 2 D (n = 915 from the prostate cancer set). Logistic regression analyses did not indicate A total of 1833 individuals from the prostate nested case-control set were included in the genetic analyses of 95 SNPs. Figure 1 shows the per-allele log odds ratio for each SNP and telomere length (dichotomized by the median). Only rs41400444 (retinoid X receptor alpha; RXRA) showed a positive association after correcting for multiple testing (per-allele OR 1.67, 95 % CI 1.26-2.19, P-trend = 0.0003; Supplemental Table S1 ). Five additional SNPs in VDR, CYP24A1 and RXRA were nominally associated with long telomere length (P < 0.05). In the global pathway analyses, we did not observe an association between the total pathway SNP set and telomere length (P = 0.41) or any SNP sets defined by specific genes (Supplemental table S1). Assessing the association between the SNPs and continuous LTL, z-score did not change the results considerably.
Discussion
In this cross-sectional study of white men, we did not observe an association between vitamin D biomarkers (25(OH)D and 1,25(OH) 2 D) and leukocyte telomere length. The lack of association remained when restricting the analyses to healthy men. One SNP in the RXRA gene showed a statistically significant positive association with Consistent with other studies [7, 10, [22] [23] [24] [25] [26] [27] , we found that BMI and smoking were inversely associated with telomere length. Due to their G-rich nucleotide sequence, telomeres are highly sensitive to oxidative stress [28] , which together with inflammation are probable mechanisms mediating the effects of BMI and smoking on telomere length [29, 30] .
Two previous cross-sectional studies in women suggest a modest, but significantly positive association between 25(OH)D and telomere length [10, 11] . A possible explanation for the lack of an association in the present study is the relatively old age of the participants. For example, the study by Richards et al. [12] which found an association between 25(OH)D and telomere length included much younger women (aged 18-80 years, mean age = 49.4 years), whereas the age range in our study was 46-81 years, and mean age = 64.1 years. However, the study by Liu et al. was conducted in women of a similar age range (43-68 years, mean age = 59.4 years) and did observe a positive, although modest association. Since men, in general, have shorter telomeres than women, we [31] . Second, since males are heterogametic (XY) any flaw in telomere maintenance alleles of the unguarded X chromosome may give rise to shorter telomeres [32] . One individual SNP (rs41400444) in the RXRA gene was associated with longer telomere length. The 1,25(OH)2D-VDR complex forms a heterodimer with the RXRA in the cell nucleus before attaching to target genes [33] , but RXR has other roles in the cell that are independent of the vitamin D pathway [34] . Therefore, the association between one common variant and long telomere length does not necessarily imply a link between the vitamin D pathway and telomere length. Moreover, this finding should be interpreted with caution given the high number of tests.
The strength of our study includes a large sample size, and it is the first study to assess the association between With the cross-sectional design, we could not assess the impact of change in vitamin D concentration on telomere attrition rate. A longitudinal study with repeated measurements would provide a more comprehensive view of the effect on leukocyte telomere dynamics. The detection of absolute levels of 25(OH)D are controversial and may differ by assay. Thus, because the 25(OH)D assays differed across cohorts and were not calibrated to a common gold standard, we were unable to assess absolute cut points for 25(OH)D. However, relative rankings adjusting for batch and season used in our analysis should reasonably robust. Because the study was conducted in men of European ancestry and it is known that vitamin D concentrations and telomere dynamics vary by ethnicity, the results may not be generalizable to other ethnicities. Finally, although all analyses were adjusted for multiple covariates, unmeasured or residual confounding could still be present. Since we did not observe evidence of strong confounding, it is, however, unlikely that unmeasured confounding alone would explain the lack of an observed association.
In conclusion, this study did not show an association between biomarkers of vitamin D (25(OH)D and 1,25(OH) 2 D) and telomere length. Since higher plasma 25(OH)D concentrations have been shown to be associated with longer telomere length in women, a sex difference in the association cannot be excluded.
